Unfinished tasks occupy your brain differently than completed ones. Discover why "done" matters more than "perfect"—and how to engineer closure.

Google and Apple have jointly announced they're working to make it easier to swap between phones running iOS and Android, with the latest Android Canary release giving us a preview of how it could all ...

The company signed a supply arrangement that might last for a decade. Beta wrote in a press release that it has been selected to provide pusher motors for electric vertical take-off and landing (eVTOL ...

The deal with a company owned by Embraer gives Beta Technologies an additional source of revenue as it develops its own electric aircraft. By Niraj Chokshi Two companies racing to develop electric ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blockers did not improve clinical outcomes after ...

The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...

Shares of electric aviation startup Beta Technologies took flight Tuesday as the company made its debut on the New York Stock Exchange with an outsized raise of $1 billion and a stock price that ...

BETA Technologies is following a vertically integrated model similar to Tesla’s, starting with niche markets (cargo, defense) before expanding into passenger aviation. BETA's robust order backlog, ...

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...

Two new studies point in opposite directions. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...